1. Home
  2. DOMO vs VYGR Comparison

DOMO vs VYGR Comparison

Compare DOMO & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$9.07

Market Cap

477.0M

Sector

Technology

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.26

Market Cap

232.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMO
VYGR
Founded
2010
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
477.0M
232.4M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
DOMO
VYGR
Price
$9.07
$4.26
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$14.38
$17.00
AVG Volume (30 Days)
918.6K
474.3K
Earning Date
12-04-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$318,002,000.00
$31,316,000.00
Revenue This Year
$2.32
N/A
Revenue Next Year
$2.72
$71.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.01
$2.65
52 Week High
$18.49
$6.55

Technical Indicators

Market Signals
Indicator
DOMO
VYGR
Relative Strength Index (RSI) 29.99 49.54
Support Level $8.40 $3.74
Resistance Level $11.88 $4.51
Average True Range (ATR) 0.54 0.21
MACD -0.11 0.04
Stochastic Oscillator 18.53 66.92

Price Performance

Historical Comparison
DOMO
VYGR

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: